Table 2.
Necrosis rate and apoptotic rate of the RAW264.7 cells under the different treatments
| Groups | N | Apoptosis rate | Necrosis rate |
|---|---|---|---|
| Control | 6 | 3.30 ± 1.01 | 2.21 ± 0.21 |
| LEV | 6 | 6.60 ± 1.78* | 2.28 ± 0.35 |
| LEV-NPs | 6 | 10.42 ± 0.84*# | 4.20 ± 1.04*# |
| US | 6 | 8.76 ± 0.78* | 9.54 ± 0.88*# |
| LEV + US | 6 | 15.54 ± 1.30*# | 7.82 ± 044*# |
| LEV-NPs + US | 6 | 21.25 ± 1.15*# | 8.21 ± 0.66*# |
LEV: levofloxacin; LEV-NPs: levofloxacin-loaded PLGA nanoparticles; US: ultrasonic; SD: standard deviation
Compared with the control, *P < 0.05; compared with the LEV, #P < 0.05. Data represent the mean ± SD